Purity for clarity: the need for purification of tumor cells in DNA microarray studies

It is now well established that gene expression profiling using DNA microarrays can provide novel information about various types of hematological malignancies, which may lead to identification of novel diagnostic markers. However, to successfully use microarrays for this purpose, the quality and reproducibility of the procedure need to be guaranteed. The quality of microarray analyses may be severely reduced, if variable frequencies of nontarget cells are present in the starting material. To systematically investigate the influence of different types of impurity, we determined gene expression profiles of leukemic samples containing different percentages of nonleukemic leukocytes. Furthermore, we used computer simulations to study the effect of different kinds of impurity as an alternative to conducting hundreds of microarray experiments on samples with various levels of purity.As expected, the percentage of erroneously identified genes rose with the increase of contaminating nontarget cells in the samples. The simulations demonstrated that a tumor load of less than 75% can lead to up to 25% erroneously identified genes. A tumor load of at least 90% leads to identification of at most 5% false-positive genes. We therefore propose that in order to draw well-founded conclusions, the percentage of target cells in microarray experiment samples should be at least 90%.

[1]  J. Cawley,et al.  The diagnosis and treatment of hairy-cell leukaemia. , 2002, Blood reviews.

[2]  W. Gillanders,et al.  The molecular detection of micrometastatic breast cancer. , 2003, American journal of surgery.

[3]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Sealfon,et al.  Validated Genomic Approach to Study Differentially Expressed Genes in Complex Tissues , 2002, Neurochemical Research.

[5]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[6]  Impact of RNA extraction from limited samples on microarray results. , 2003, BioTechniques.

[7]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[8]  M J T Reinders,et al.  DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers , 2003, Leukemia.

[9]  E. Southern,et al.  Molecular interactions on microarrays , 1999, Nature Genetics.

[10]  Yongchao Ge.  Resampling-based Multiple Testing for Microarray Data Analysis , 2003 .

[11]  D. Nance,et al.  Interactions between cancer cells and the endothelium in metastasis , 2000, The Journal of pathology.

[12]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[13]  Yusuke Nakamura,et al.  Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection , 2004, Oncogene.

[14]  R. Timpl,et al.  The laminins. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[15]  Hiroyuki Honda,et al.  Multiple fuzzy neural network system for outcome prediction and classification of 220 lymphoma patients on the basis of molecular profiling , 2003, Cancer science.

[16]  Ugur Sahin,et al.  Computational dissection of tissue contamination for identification of colon cancer‐specific expression profiles , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  E. Klar,et al.  Minimal residual disease in thyroid carcinoma. , 2001, Seminars in surgical oncology.

[18]  Rong-yu Li,et al.  Systematic comparison of the fidelity of aRNA, mRNA and T-RNA on gene expression profiling using cDNA microarray. , 2004, Journal of biotechnology.

[19]  F. Behm,et al.  Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. , 1993, Blood.

[20]  P. Brown,et al.  Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Wang-Rodriguez,et al.  In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Cheng Cheng,et al.  Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. , 2004, The New England journal of medicine.

[23]  M. Stolte,et al.  Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists , 2001, Journal of Gastroenterology.

[24]  Ash A. Alizadeh,et al.  Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. , 2004, The New England journal of medicine.

[25]  John D Potter,et al.  Epidemiology, cancer genetics and microarrays: making correct inferences, using appropriate designs. , 2003, Trends in genetics : TIG.

[26]  A. Gown,et al.  Immunohistochemical analysis of gynecologic tumors. , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[27]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[28]  A. Witkamp,et al.  Peritoneal carcinomatosis from colorectal or appendiceal origin: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement , 2004, Journal of surgical oncology.

[29]  中村 透.  Genome-wide cDNA microarray analysis of gene-expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection , 2004 .

[30]  John D. Storey,et al.  SAM Thresholding and False Discovery Rates for Detecting Differential Gene Expression in DNA Microarrays , 2003 .

[31]  C. Barden,et al.  Discrimination of Benign and Malignant Thyroid Nodules by Molecular Profiling , 2004, Annals of surgery.

[32]  T. B. Taylor,et al.  High-quality RNA from cells isolated by laser capture microdissection. , 2002, BioTechniques.

[33]  Aleksey A. Nakorchevskiy,et al.  Expression deconvolution: A reinterpretation of DNA microarray data reveals dynamic changes in cell populations , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Lander,et al.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.

[36]  Andrew J. Holloway,et al.  Options available—from start to finish—for obtaining data from DNA microarrays II , 2002, Nature Genetics.

[37]  Remco Dijkman,et al.  Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. , 2005, Blood.

[38]  Kevin Gardner,et al.  Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Tatjana Crnogorac-Jurcevic,et al.  Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer , 2003, Oncogene.

[40]  R. Verhaak,et al.  Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.

[41]  G. Murphy,et al.  Prostate-specific membrane antigen (PSMA): current benefits and future value. , 2000, Seminars in surgical oncology.

[42]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[43]  L. Sabatier,et al.  B-cell chronic lymphocytic leukaemia: a polymorphic family unified by genomic features. , 2003, The Lancet. Oncology.

[44]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[45]  Gudrun Schleiermacher,et al.  Gene expression profiling of 1p35–36 genes in neuroblastoma , 2004, Oncogene.

[46]  M J T Reinders,et al.  DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers , 2004, Leukemia.

[47]  John D. Storey.  A direct approach to false discovery rates , 2002 .

[48]  J. Coindre,et al.  Immunohistochemistry in the diagnosis of soft tissue tumours , 2003, Histopathology.

[49]  O. Hrusak,et al.  Antigen expression patterns reflecting genotype of acute leukemias , 2002, Leukemia.

[50]  H Llewellyn,et al.  Observer variation, dysplasia grading, and HPV typing: a review. , 2000, American journal of clinical pathology.